C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2002
11/12/2002	US6479463 Used to treat an infection, an infestation, a neoplasm, or an autoimmune disease or to modulate aspects of the immune system, including modulation of th1 and th2
11/12/2002	US6479233 Electrogenerated chemiluminescence labels for analysis and/or referencing
11/12/2002	CA2092435C Uracil reductase inactivators
11/07/2002	WO2002088382A2 Method for analysing nucleic acid chains
11/07/2002	WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002	WO2002087465A2 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	WO2001020035A9 Methods and compositions for linear isothermal amplification of polynucleotide sequences
11/07/2002	US20020165389 Multiple-labelled oligonucleotides synthesized on solid-supports
11/07/2002	US20020165372 Nucleic acid labeling compounds
11/07/2002	US20020165239 Conjugates of sodium channel blockers and methods of using the same
11/07/2002	US20020165199 Nucleosides for imaging and treatment applications
11/07/2002	US20020165197 Administering adenosine receptor ligand
11/07/2002	US20020164590 Solid support for use in the determination, classification and mapping of biopolymer sequences
11/07/2002	CA2594883A1 Pharmaceutically active uridine esters
11/07/2002	CA2445861A1 Pharmaceutically active uridine esters
11/07/2002	CA2445565A1 Compositions and methods of double-targeting virus infections and cancer cells
11/06/2002	EP1254911A1 Monocyclic L-nucleosides, analogs and uses thereof
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002	EP0748382B1 Non-nucleotide containing enzymatic nucleic acid
11/06/2002	EP0650520B1 Process for the production of saccharose-synthase
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378550A Partial or full A1 agonists-N6 heterocyclic 5' thio substituted adenosine devivatives
11/05/2002	US6476216 Preparation of phosphorothioate oligomers
11/05/2002	US6476205 2′ Modified oligonucleotides
11/05/2002	US6475985 Nucleosides with antiviral and anticancer activity
11/05/2002	US6475509 Covalent conjugates of sodium channel blockers and active compounds
10/2002
10/31/2002	WO2002086165A1 Biological sample processing methods and compositions that include surfactants
10/31/2002	WO2002086139A1 Antibiotic aa 896 analogs
10/31/2002	WO2002086088A2 Polymerases with charge-switch activity and methods of generating such polymerases
10/31/2002	WO2002085867A1 Antibiotics aa-896
10/31/2002	WO2002085403A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
10/31/2002	WO2002085310A2 Antibiotics aa-896
10/31/2002	WO2002062123A3 Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	WO2002028874A3 Tumor proliferation inhibitors
10/31/2002	US20020161220 Tetraphosphonate bicyclic trisanhydrides
10/31/2002	US20020160980 Method of treating hepatitis delta virus infection
10/31/2002	US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
10/31/2002	US20020160969 Nucleosides and oligonucleotides containing boron clusters
10/31/2002	US20020160379 Gapped 2' modified oligonucleotides
10/31/2002	US20020158255 Compounds of the general formula P1-L-P2; wherein "P1" is a pyrazinoylguanidine sodium channel blocker, "L" is a linking group, and "P2" is either (i) a pyrazinoylguanidine sodium channel blocker or (ii) a P2Y2 receptor agonist, are disclosed
10/31/2002	CA2444967A1 Biological sample processing methods and compositions that include surfactants
10/31/2002	CA2444907A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
10/30/2002	EP1253199A1 Abasic moieties containing enzymatic nucleic acids
10/30/2002	EP1253154A1 Method for purifying 5'-protected 2'-deoxypurine nucleosides
10/30/2002	EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252176A2 Nucleic acids, proteins, and antibodies
10/30/2002	EP1252173A1 Purification of oligonucleotides
10/30/2002	EP1051425B1 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
10/30/2002	CN1376674A Production of 5'-guanylate disodium. 5'-inosine disodium mixed crystals
10/29/2002	US6473512 Apparatus and method for a custom soft-solid hearing aid
10/29/2002	US6472541 Halogenated- coumarin, quinoline-2-one, xanthene, thioxanthene, selenoxanthenen, or anthracene derivatives; irradiating to control the release of the sompound spatially and temporally to probe its biological effects
10/29/2002	US6472384 Antimicrobial compounds
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083703A1 Composition based on a s-adenosyl-l-methionine polyphosphate and uses of such a polyphosphate
10/24/2002	WO2002083702A1 Process for selective n-acylation of purine nucleosides
10/24/2002	WO2002083152A1 Activation of natural killer cells by adenosine a3 receptor agonists
10/24/2002	WO2002083150A1 Bisphosphonate conjugates and methods of making and using the same
10/24/2002	WO2001051661A3 A universal nucleic acid amplification system for nucleic acids in a sample
10/24/2002	US20020156269 Crystals of diuridine tetraphosphate or salt thereof, process for producing the crystals, and process for producing the compounds
10/24/2002	US20020156030 Heterocyclic aromatic compounds and uses thereof
10/24/2002	US20020155999 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
10/24/2002	US20020155989 Protein nucleic acid molecules
10/24/2002	US20020155588 Very large scale immobilized polymer synthesis
10/24/2002	US20020155492 Arrays for detecting nucleic acids
10/24/2002	US20020155491 Arrays for detecting nucleic acids
10/24/2002	US20020155150 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients
10/24/2002	CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/23/2002	EP1250348A1 Antisense modulation of daxx expression
10/23/2002	EP1250128A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
10/23/2002	CN1376161A Novel bicyclonucleoside analogues
10/22/2002	US6469160 Crystalline forms of an antiviral benzimidazole compound
10/22/2002	US6468991 Method of treating rhinoviral infections
10/17/2002	WO2002081476A1 Thiophosphate nucleic acid-based compounds
10/17/2002	WO2002068437A9 Protected deoxyadenosines and deoxyguanosines
10/17/2002	US20020151711 Nucleotide compounds including a rigid linker
10/17/2002	US20020150943 Genotyping by mass spectrometric analysis of allelic fragments
10/17/2002	US20020150936 Biosynthesis of 2'-O-silyl-nucleoside phosphoramidite; obtain nucleoside, incubate with silyl compound, desilylate, incubate with phosphoramidate, recover nucleoside phosphoramidate
10/17/2002	US20020150927 Methods for detecting a plurality of analytes by mass spectrometry
10/17/2002	DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/16/2002	EP0948509B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/16/2002	EP0637965B1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
10/16/2002	CN1374967A Compounds for the treatment of ischemia
10/16/2002	CN1374966A 嘌呤衍生物 Purine derivatives
10/15/2002	US6465641 One pot synthesis of 5′-hydroxy phosphorylated nucleoside derivatives, and compounds formed thereby
10/15/2002	US6465625 Taxol derivatives

1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 201